NeueHealth (NYSE:NEUE) Issues Quarterly Earnings Results

NeueHealth (NYSE:NEUE) released its quarterly earnings data on Thursday. The company reported ($7.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.29) by ($5.12), Zacks reports. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%.

NeueHealth Stock Up 8.7 %

NYSE NEUE traded up $0.42 during trading hours on Thursday, hitting $5.26. 10,596 shares of the company were exchanged, compared to its average volume of 19,330. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66. The stock has a 50-day moving average price of $7.11 and a 200 day moving average price of $6.00. The stock has a market cap of $43.58 million, a PE ratio of -0.10 and a beta of 0.56.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada decreased their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

Insider Activity

In other news, CEO George Lawrence Mikan III sold 31,798 shares of the firm’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $233,079.34. Following the completion of the sale, the chief executive officer now owns 146,539 shares in the company, valued at approximately $1,074,130.87. This trade represents a 17.83 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $6.74, for a total transaction of $29,979.52. Following the transaction, the chief financial officer now owns 41,592 shares in the company, valued at $280,330.08. The trade was a 9.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 110,033 shares of company stock valued at $774,560 in the last ninety days. Insiders own 64.30% of the company’s stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.